Fulvic Acid & Tuberculosis.
Historical clinical literature on Fulvic Acid includes an interesting observation involving a patient with tuberculosis who was experiencing coughing of blood. The research is particularly notable for its focus on bleeding and blood coagulation.
An unexpected chapter in Fulvic Acid research.
The historical literature reviewed on this page comes from clinical observations made in China during the late 1970s. The work was not a tuberculosis treatment trial; rather, it investigated Fulvic Acid in patients suffering from bleeding. One of the six patients who were coughing blood had tuberculosis, making this case particularly relevant to the topic.
What happened in the tuberculosis case?
The historical report describes six patients who were coughing blood: four with bronchiectasis, one with tuberculosis and one with heart failure. The tuberculosis patient received the same Fulvic Acid protocol used for the bleeding cases. The report states that the patient was improving and that blood coagulation occurred by the third day. The report also states that the patient later experienced a relapse. This makes the observation scientifically interesting, while showing why it should be understood as a historical case report rather than proof of a tuberculosis treatment.
The interesting part is the biological response.
Fulvic Acid was being investigated in this historical work because of observations around blood coagulation. Experimental observations cited in the same literature also reported accelerated clotting responses following Fulvic Acid administration. This provides an interesting direction for research into the interaction between Fulvic compounds and biological systems.
Fulvic Acid
A natural organic complex investigated for mineral interactions, antioxidant activity and biological effects. Historical clinical work also explored its relationship with blood coagulation.
Humic Acid
A naturally occurring humic substance studied for antioxidant, anti-inflammatory and broader biological activity.
Shilajit
Naturally contains Fulvic Acid, Humic substances, minerals and other bioactive compounds, bringing together several components of interest for cellular and systemic research.
One historical case. A bigger research question.
The tuberculosis observation does not establish Fulvic Acid as a tuberculosis treatment. What it does provide is an intriguing historical clinical observation linking Fulvic Acid with a change in bleeding in a patient with tuberculosis — a small piece of evidence that helps explain why Fulvic and Humic substances continue to attract scientific interest.
Explore the research.
Scientific references are provided for educational purposes. The historical tuberculosis observation involved one patient and focused on bleeding, not eradication of tuberculosis. Fulvic Acid, Humic Acid and Shilajit should not be presented as substitutes for established tuberculosis diagnosis or treatment.